{"url_path":"/sec/abvc/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1173313/0001213900-26-058104-index.html","accession_number":"0001213900-26-058104","cik":"0001173313","ticker":"ABVC","issuer_name":"ABVC BIOPHARMA, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1173313/0001213900-26-058104-index.html","primary_entity_key":"0001173313","primary_entity_name":"ABVC BIOPHARMA, INC."},"word_count":423,"has_tables":true,"body_markdown":"**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n** **\n\n**FORM 10-Q**\n\n \n\n☒\nQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor the quarterly period ended March 31, 2026\n\n \n\n☐\nTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor the transition period from ____________ to\n____________\n\n \n\nCommission file number **001-40700**\n\n \n\n**ABVC BioPharma, Inc.**\n\n(Exact name of Registrant as specified in its\ncharter)\n\n \n\n**Nevada**   **26-0014658**\n\nState or jurisdiction of\nincorporation or organization   IRS Employer\nIdentification Number\n\n \n\n**44370 Old Warm Springs Blvd.**\n\n**Fremont, CA 94538**\n\n**Tel: (510) 668-0881**\n\n(Address and telephone number of principal executive\noffices)\n\n \n\n \n\n(Former name, if changed since last report)\n\n \n\nSecurities registered pursuant to Section 12(b)\nof the Act:\n\n \n\n**Title of each class**   **Trading Symbol(s)**   **Name of each exchange on which registered**\n\nCommon Stock, par value $0.001 per share   ABVC   The Nasdaq Stock Market LLC\n\n \n\nIndicate by check mark whether the issuer (1)\nfiled all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period\nthat the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. Yes\n☒ No ☐\n\n \n\nIndicate by check mark whether the registrant\nhas submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405\nof this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes\n☒ No ☐\n\n \n\nIndicate by check mark whether the registrant\nis a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.\nSee the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”\nand “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer ☐ Accelerated filer ☐\n\nNon-accelerated filer ☒ Smaller reporting company ☒\n\n  Emerging growth company ☐\n\n \n\nIf an emerging growth company, indicate by check\nmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting\nstandards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate by check mark whether the registrant\nis a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐\nNo ☒\n\n \n\nAs of May 14, 2026, there were 26,000,442 shares\nof common stock, par value per share $0.001, issued and outstanding.\n\n \n\n \n\n \n\n \n\n \n\n \n\n**TABLE OF CONTENTS**\n\n \n\n**PART I**\n**FINANCIAL INFORMATION**\nF-1"}